Abstract
Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas Including AITL and DLBCL: Phase I Results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have